Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Patients face uncertainty after discovering their source of affordable obesity drugs was unlicensed.
Patients who bought affordable obesity drugs from a website are now unsure of their options after discovering the compounding pharmacy lacked the necessary license.
These patients stockpiled alternative GLP-1 drugs, raising concerns about the legality and safety of their purchases.
The situation, reported by NPR's Sydney Lupkin, leaves both patients and medical facilities in uncertainty.
12 Articles
Los pacientes se enfrentan a la incertidumbre después de descubrir que su fuente de medicamentos de obesidad asequibles no fue licenciada.